| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.3 |